Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-057845
Filing Date
2015-10-02
Accepted
2015-10-02 14:24:33
Documents
1
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 form476160_20151002022412-.html 4  
1 form476160_20151002022412-.xml 4 5959
  Complete submission text file 0001144204-15-057845.txt   7411
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Issuer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LIPOCINE, INC. 675 ARAPEEN DRIVE, STE. 202 SALT LAKE CITY UT 84108
Business Address
Patel Mahesh V. (Reporting) CIK: 0001579872 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36357 | Film No.: 151139725